These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8386921)

  • 21. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
    Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S
    Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt U; Friisberg B; Bonnevie-Nielsen V; Svendsen PA
    Acta Endocrinol Suppl (Copenh); 1981; 242():39-40. PubMed ID: 6940399
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medicamentous kidney protection in type 2 diabetic patients--is cheaper also more economical? A model calculation for Swiss health care].
    Faller J; Hess B
    Praxis (Bern 1994); 2002 May; 91(19):836-44. PubMed ID: 12071084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.
    Degaute JP; Leeman M; Reuse C; Carlier E; Schoutens A; Vandepapeliere P
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):489-94. PubMed ID: 1333275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.
    Bakris GL; Slataper R; Vicknair N; Sadler R
    J Diabetes Complications; 1994; 8(1):2-6. PubMed ID: 8167383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
    Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
    August P; Lenz T; Laragh JH
    Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive therapy and progression of diabetic renal disease.
    Hoelscher D; Bakris G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S34-8. PubMed ID: 7519695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
    Bakris GL; Smith A
    Ann Intern Med; 1996 Aug; 125(3):201-4. PubMed ID: 8686978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of delayed graft function in cadaveric kidney transplants by the calcium antagonist diltiazem and the prostacyclin-analogue iloprost--outcome of a prospective randomized clinical trial.
    Neumayer HH; Schreiber M; Wagner K
    Prog Clin Biol Res; 1989; 301():289-95. PubMed ID: 2477852
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal plasma flow and glomerular filtration rate during antihypertensive therapy in essential hypertension.
    Pedersen EB; Danielsen H; Eiskjaer H; Jespersen B; Sørensen SS; Thomsen OO
    Dan Med Bull; 1987 Dec; 34 Suppl 1():7-8. PubMed ID: 3436171
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.
    Gaber L; Walton C; Brown S; Bakris G
    Kidney Int; 1994 Jul; 46(1):161-9. PubMed ID: 7933834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Converting enzyme-inhibition in diabetic nephropathy.
    Mathiesen ER; Parving HH; Hommel E
    Contrib Nephrol; 1989; 73():160-1; discussion 161-2. PubMed ID: 2689092
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome variables in the assessment of progression of diabetic kidney disease.
    Viberti G
    Kidney Int Suppl; 1994 Feb; 45():S121-4. PubMed ID: 8158880
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-protein diet and progression of diabetic kidney disease.
    Viberti GC
    Nephrol Dial Transplant; 1988; 3(3):334-9. PubMed ID: 3140110
    [No Abstract]   [Full Text] [Related]  

  • 38. Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy.
    Ogawa S; Nako K; Okamura M; Senda M; Mori T; Ito S
    Hypertens Res; 2011 Mar; 34(3):400-1. PubMed ID: 21160485
    [No Abstract]   [Full Text] [Related]  

  • 39. Glomerular hyperfiltration, intrarenal hemodynamics, and chronic allograft nephropathy: physiopathology of chronic allograft nephropathy.
    Solà R; Paredes D; Antonijoan RM; Estorch M; Vila LP; Guirado LL; Diaz JM; Gich I; Barbanoj MJ
    Transplant Proc; 2002 Feb; 34(1):340-2. PubMed ID: 11959315
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative effect of different antihypertensive agents through hemodynamic analysis].
    Hartleb O; Nocker J
    Rev Bras Med; 1967 Jul; 24(7):585-8. PubMed ID: 5613813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.